Indefinite Delivery Contract 36E79721D0023
Award Date
5/21/21
Last Date to Order
5/20/26
Federal Agency
National Acquisition Center
Awardee
Marlex Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
The Defense Logistics Agency Troop Support Medical, a defense agency, has awarded Marlex Pharmaceuticals Inc., a minority-owned, self-certified small disadvantaged business, an Indefinite Delivery Contract (IDC) with a ceiling value of $9,215,304.68. The contract is for the manufacture and distribution of a variety of generic pharmaceutical products, including medications such as prednisone, haloperidol, methocarbamol, loratadine, cetirizine, and others, to support federal healthcare programs....
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
This Indefinite Delivery Contract (IDC) award to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, was issued by the Defense Logistics Agency (DLA) with a ceiling value of $5,592,523.40 and a period of performance through June 7, 2026. The contract is for the manufacture and distribution of various pharmaceutical products, primarily generic medications such as ibuprofen, citalopram, oseltamivir phosphate, and alfuzosin HCl, to support federal healthcare programs...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer, to supply allopurinol tablets in various strengths to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award IDC has a base year plus four one-year option periods, with a total ceiling value of $26,069,655.90. The contract will utilize the...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Marlex Pharmaceuticals Inc. to provide baclofen tablets. The contract has a potential value of $17,702,067.50 and a period of performance from July 1, 2020, to June 30, 2025, with four one-year option periods. Marlex Pharmaceuticals Inc., a minority-owned and small disadvantaged business, is the sole provider of baclofen tablets under this contract. The agency estimates...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods. The contract is for the supply of losartan...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...